New challenges for humanitarian protection

Por Bruderlein, Claude, Leaning, Jennifer
Publicado em 1999

Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.

Por Koretz, K., Brüderlein, S., Henne, C., Möller, P.
Publicado em 1993

Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.

Por Koretz, K., Brüderlein, S., Henne, C., Möller, P.
Publicado em 1992

Hope and despair over health in Gaza

Por Hill, Allan G, Clark, Cari Jo, Lubbad, Ismail, Bruderlein, Claude
Publicado em 2006

Sex-related differences in length and erosion dynamics of human telomeres favor females

Por Möller, Peter, Mayer, Susanne, Mattfeldt, Torsten, Müller, Kathrin, Wiegand, Peter, Brüderlein, Silke
Publicado em 2009

3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps"

Por Knecht, Hans, Brüderlein, Silke, Wegener, Silke, Lichtensztejn, Daniel, Lichtensztejn, Zelda, Lemieux, Bruno, Möller, Peter, Mai, Sabine
Publicado em 2010

Expression and Y435-phosphorylation of Abelson interactor 1 (Abi1) promotes tumour cell adhesion, extracellular matrix degradation and invasion by colorectal carcinoma cells

Por Steinestel, Konrad, Brüderlein, Silke, Lennerz, Jochen K, Steinestel, Julie, Kraft, Klaus, Pröpper, Christian, Meineke, Viktor, Möller, Peter
Publicado em 2014

Expression of Abelson Interactor 1 (Abi1) Correlates with Inflammation, KRAS Mutation and Adenomatous Change during Colonic Carcinogenesis

Por Steinestel, Konrad, Brüderlein, Silke, Steinestel, Julie, Märkl, Bruno, Schwerer, Michael J., Arndt, Annette, Kraft, Klaus, Pröpper, Christian, Möller, Peter
Publicado em 2012

Molecular Characterization of Putative Chordoma Cell Lines

Por Brüderlein, Silke, Sommer, Joshua B., Meltzer, Paul S., Li, Sufeng, Osada, Takuya, Ng, David, Möller, Peter, Alcorta, David A., Kelley, Michael J.
Publicado em 2010

CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients

Por Schlitter, Anne-Marie, Dorneburg, Carmen, Barth, Thomas F. E., Wahl, Joachim, Schulte, Johannes H., Brüderlein, Silke, Debatin, Klaus-Michael, Beltinger, Christian
Publicado em 2012

Quantifying Telomere Lengths of Human Individual Chromosome Arms by Centromere-Calibrated Fluorescence in Situ Hybridization and Digital Imaging

Por Perner, Sven, Brüderlein, Silke, Hasel, Cornelia, Waibel, Irena, Holdenried, Alexandra, Ciloglu, Neslisah, Chopurian, Heiko, Nielsen, Kirsten Vang, Plesch, Andreas, Högel, Josef, Möller, Peter
Publicado em 2003

Lymphocytes of Type 2 Diabetic Women Carry a High Load of Stable Chromosomal Aberrations : A Novel Risk Factor for Disease-Related Early Death

Por Boehm, Bernhard O., Möller, Peter, Högel, Josef, Winkelmann, Bernhard R., Renner, Wilfried, Rosinger, Silke, Seelhorst, Ursula, Wellnitz, Britta, März, Winfried, Melzner, Julia, Brüderlein, Silke
Publicado em 2008

STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)

Por Ritz, Olga, Rommel, Karolin, Dorsch, Karola, Kelsch, Elena, Melzner, Julia, Buck, Michaela, Leroy, Karen, Papadopoulou, Vasiliki, Wagner, Simon, Marienfeld, Ralf, Brüderlein, Silke, Lennerz, Jochen K., Möller, Peter
Publicado em 2013

FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma

Por Xie, Linka, Ritz, Olga, Leithäuser, Frank, Guan, Hanfeng, Färbinger, Johanna, Weitzer, Clarissa D., Gehringer, Franziska, Brüderlein, Silke, Holzmann, Karlheinz, Vogel, Marion J., Möller, Peter, Wirth, Thomas, Ushmorov, Alexey
Publicado em 2014

Molecular profiling of chordoma

Por SCHEIL-BERTRAM, STEFANIE, KAPPLER, ROLAND, VON BAER, ALEXANDRA, HARTWIG, ERICH, SARKAR, MICHAEL, SERRA, MASSIMO, BRÜDERLEIN, SILKE, WESTHOFF, BETTINA, MELZNER, INGO, BASSALY, BIRGIT, HERMS, JOCHEN, HUGO, HEINZ-HERMANN, SCHULTE, MICHAEL, MÖLLER, PETER
Publicado em 2014

KIT mutations in primary mediastinal B-cell lymphoma

Por Nagel, P D, Stenzinger, A, Feld, F M, Herrmann, M D, Brüderlein, S, Barth, T F E, Marienfeld, R, Endris, V, Weichert, W, Debatin, K-M, Westhoff, M-A, Lessel, D, Möller, P, Lennerz, J K
Publicado no Blood Cancer J (2014)

HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas

Por Jäger, Daniela, Barth, Thomas F. E., Brüderlein, Silke, Scheuerle, Angelika, Rinner, Beate, von Witzleben, Adrian, Lechel, André, Meyer, Patrick, Mayer-Steinacker, Regine, Baer, Alexandra von, Schultheiss, Markus, Wirtz, Christian R., Möller, Peter, Mellert, Kevin
Publicado no Sci Rep (2017)

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

Por Michael J. Böhm, Ralf Marienfeld, Daniela Jäger, Kevin Mellert, Adrian von Witzleben, Silke Brüderlein, Mathias Wittau, Alexandra von Baer, Markus Schultheiss, Regine Mayer-Steinacker, Frank G. Rücker, Peter Möller, Lars Bullinger, Thomas F. E. Barth
Publicado em 2019-01-01

Potential clinical implications of BRAF mutations in histiocytic proliferations

Por Bubolz, Anna-Maria, Weissinger, Stephanie E., Stenzinger, Albrecht, Arndt, Annette, Steinestel, Konrad, Brüderlein, Silke, Cario, Holger, Lubatschofski, Anneli, Welke, Claudia, Anagnostopoulos, Ioannis, Barth, Thomas F. E., Beer, Ambros J., Möller, Peter, Gottstein, Martin, Viardot, Andreas, Lennerz, Jochen K.
Publicado em 2014

EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen

Por Scheipl, Susanne, Barnard, Michelle, Cottone, Lucia, Jorgensen, Mette, Drewry, David H, Zuercher, William J, Turlais, Fabrice, Ye, Hongtao, Leite, Ana P, Smith, James A, Leithner, Andreas, Möller, Peter, Brüderlein, Silke, Guppy, Naomi, Amary, Fernanda, Tirabosco, Roberto, Strauss, Sandra J, Pillay, Nischalan, Flanagan, Adrienne M
Publicado no J Pathol (2016)